带状疱疹疫苗市场（按产品类型）- 2024-2030 年全球预测

带状疱疹疫苗市场，按产品类型分類的市场规模预计到 2023 年为 3.4244 亿美元，2024 年达到 3.7907 亿美元，2030 年达到 6.4312 亿美元，复合年增长率为 9.42%。

按产品类型分類的带状疱疹疫苗的全球市场

FPNV定位矩阵

FPNV 定位矩阵对于按产品类型评估带状疱疹疫苗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以按产品类型对带状疱疹疫苗市场、供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-带状疱疹疫苗市场、市场规模和产品类型预测是多少？

2-带状疱疹疫苗市场预测期间需要考虑投资的产品、细分市场、应用和领域（按产品类型划分）有哪些？

3-带状疱疹疫苗市场按产品类型的技术趋势和法律规范是什么？

4-带状疱疹疫苗市场主要供应商按产品类型分類的市场占有率是多少？

5-按产品类型划分，进入带状疱疹疫苗市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 慢性病盛行率增加
    • 老年人口增加
    • 疫苗接种越来越受到世界各地的关注
  • 抑制因素
    • 疫苗研发需要大量资金
  • 机会
    • 带状疱疹疫苗的研发
    • 企业在疫苗研发方面的新倡议
  • 任务
    • 带状疱疹疫苗的副作用
• 市场区隔分析
• 市场趋势分析
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范

第六章带状疱疹疫苗市场，依产品类型：依产品

• 天空之星
• 佐斯塔瓦克斯
• 定序

第七章带状疱疹疫苗市场，依产品类型：依类型

• 减毒活病毒疫苗
• 重组疫苗

第八章美洲带状疱疹疫苗市场，依产品类型

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太地区带状疱疹疫苗市场（依产品类型）

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第10章欧洲/中东/非洲带状疱疹疫苗市场（依产品类型）

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争形势

• FPNV定位矩阵
• 市场占有率分析：主要企业
• 主要企业竞争情境分析

第12章竞争产品组合

• 主要公司简介
  • Biogenetech
  • CanSino Biologics Inc.
  • CSL Limited
  • Emergent Biosolutions Inc.
  • GeneOne Life Science
  • GlaxoSmithKline PLC
  • Jiangsu Recbio Technology Co., Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi-aventis Groupe
  • SK Chemicals
  • Vaccitech PLC
• 主要产品系列

第十三章附录

• 讨论指南
• 关于许可证和定价

[180 Pages Report] The Shingles Vaccine Market size was estimated at USD 342.44 million in 2023 and expected to reach USD 379.07 million in 2024, at a CAGR 9.42% to reach USD 643.12 million by 2030.

Global Shingles Vaccine Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Shingles Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Shingles Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Shingles Vaccine Market, highlighting leading vendors and their innovative profiles. These include Biogenetech, CanSino Biologics Inc., CSL Limited, Emergent Biosolutions Inc., GeneOne Life Science, GlaxoSmithKline PLC, Jiangsu Recbio Technology Co., Ltd., Merck & Co., Inc., Pfizer Inc., Sanofi-aventis Groupe, SK Chemicals, and Vaccitech PLC.

Market Segmentation & Coverage

This research report categorizes the Shingles Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • SkyZoster
  • Zostavax
  • Shingrix
• Type
  • Live Attenuated Vaccine
  • Recombinant Vaccine
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Shingles Vaccine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Shingles Vaccine Market?

3. What are the technology trends and regulatory frameworks in the Shingles Vaccine Market?

4. What is the market share of the leading vendors in the Shingles Vaccine Market?

5. Which modes and strategic moves are suitable for entering the Shingles Vaccine Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Shingles Vaccine Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases
    • 5.1.1.2. Rising number of geriatric population
    • 5.1.1.3. Growing focus on immunization across the world
  • 5.1.2. Restraints
    • 5.1.2.1. High capital necessary for vaccine development
  • 5.1.3. Opportunities
    • 5.1.3.1. Research & development on shingles vaccines
    • 5.1.3.2. Emerging initiatives from companies in research and development of vaccines
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects of shingles vaccines
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Shingles Vaccine Market, by Product

• 6.1. Introduction
• 6.2. SkyZoster
• 6.3. Zostavax
• 6.4. Shingrix

7. Shingles Vaccine Market, by Type

• 7.1. Introduction
• 7.2. Live Attenuated Vaccine
• 7.3. Recombinant Vaccine

8. Americas Shingles Vaccine Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Shingles Vaccine Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Shingles Vaccine Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Biogenetech
  • 12.1.2. CanSino Biologics Inc.
  • 12.1.3. CSL Limited
  • 12.1.4. Emergent Biosolutions Inc.
  • 12.1.5. GeneOne Life Science
  • 12.1.6. GlaxoSmithKline PLC
  • 12.1.7. Jiangsu Recbio Technology Co., Ltd.
  • 12.1.8. Merck & Co., Inc.
  • 12.1.9. Pfizer Inc.
  • 12.1.10. Sanofi-aventis Groupe
  • 12.1.11. SK Chemicals
  • 12.1.12. Vaccitech PLC
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. SHINGLES VACCINE MARKET RESEARCH PROCESS
• FIGURE 2. SHINGLES VACCINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. SHINGLES VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. SHINGLES VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. SHINGLES VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. SHINGLES VACCINE MARKET DYNAMICS
• FIGURE 7. SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. SHINGLES VACCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 10. SHINGLES VACCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. SHINGLES VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 20. SHINGLES VACCINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. SHINGLES VACCINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. SHINGLES VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SHINGLES VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 6. SHINGLES VACCINE MARKET SIZE, BY SKYZOSTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. SHINGLES VACCINE MARKET SIZE, BY ZOSTAVAX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. SHINGLES VACCINE MARKET SIZE, BY SHINGRIX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 10. SHINGLES VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. SHINGLES VACCINE MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. AMERICAS SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 15. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. BRAZIL SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. CANADA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. CANADA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. MEXICO SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES SHINGLES VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 26. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CHINA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CHINA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. INDIA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. INDIA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDONESIA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. JAPAN SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MALAYSIA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. PHILIPPINES SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. SINGAPORE SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. TAIWAN SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. THAILAND SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. VIETNAM SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA SHINGLES VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. DENMARK SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. EGYPT SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. FINLAND SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FRANCE SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. GERMANY SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. ISRAEL SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ITALY SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ITALY SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NIGERIA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NORWAY SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. POLAND SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. POLAND SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. QATAR SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. QATAR SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. RUSSIA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SPAIN SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SWEDEN SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TURKEY SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM SHINGLES VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SHINGLES VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 99. SHINGLES VACCINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. SHINGLES VACCINE MARKET LICENSE & PRICING